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Abstract  
Background: Including stakeholders in the process and outcomes of comparative effectiveness research (CER) can help 
ensure that research questions are relevant and findings are communicated to individuals who need them for decision-
making. Yet limited strategies are available to assist researchers with stakeholder engagement. While health system leaders’ 
perspectives are increasingly recognized as valuable for CER planning, their inclusion in the stakeholder pool raises 
challenges due to differences in culture, training, incentives, priorities and language norms.  
Objective: To convene and evaluate a deliberative forum for engaging health system leaders and other stakeholders in order 
to shape health system research priorities for the PaTH Clinical Data Research Network, a member of the National Patient-
Centered Clinical Research Network (PCORnet). 
Methods: Breakout sessions and large group deliberation solicited diverse perspectives and explored benefits and 
challenges of different research questions. Topic reframing, narrative integration and dynamic updating techniques 
facilitated communication across diverse backgrounds. Participants included 29 health system and health plan leaders, 
clinicians, clinical researchers and patients from the network’s 6 participating health systems. Main measures were audience 
response system (ARS) polling on general topic preferences and survey data on measures of engagement and deliberation 
success. 
Results: A slate of 10 specific research topics was vetted; after deliberation, the group converged to favor the 
characterization of high utilizers of healthcare. Audience response polling revealed opinion shifts. Participants reported high 
levels of satisfaction with the experience and rated it highly for markers of deliberative quality (e.g., opportunity for active 
participation and adequate discussion, respect for others’ opinions and awareness of different perspectives). Fifty-four 
percent noted their views on the issues changed. Most participants learned from the experience (93%) and agreed that the 
process helped them to empathize with the challenges of others (85%).  
Conclusions: A deliberation forum can incorporate diverse stakeholders into CER, enabling participants to inform and learn 
from each other’s perspectives while shaping a person-centered research trajectory. 
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Stakeholder engagement in comparative effectiveness 
research (CER) aims to ensure that research questions are 
relevant and that stakeholders are involved throughout the 
research process [1,2]. Engagement may enhance study 
recruitment, promote greater uptake of research findings 
and facilitate decision-making in participatory design [1,3]. 
While stakeholder engagement is perceived as beneficial in 
fields such as community-based participatory research 
[4,5], environmental science [6] and energy policy [7-9], 
methods for incorporating it into CER were developed 
only recently [2]. Strategies for engaging stakeholders in 
the research design process are limited [10,11] and 
researchers have called for more descriptive studies on 
stakeholder engagement in health research [12].  
Engaging a broad range of stakeholders is endorsed for 
CER [13,14] and scholars argue that patient-centered 
research should engage the spectrum of stakeholders 
involved in patient-centered healthcare (e.g., patients, 
clinicians, representatives from the delivery system and 
payers or purchasers) [13,15-17]. Yet, literature on CER 
and patient-centered research has focused primarily on 
patient engagement and little is known about engaging 
payers and key decision-makers at the health system level 
[1,12]. This project begins to fill that gap by bringing 
diverse stakeholders, including health system leaders, to 
the table. However, doing so poses challenges due to 
cultural factors, training, incentives, priorities, scheduling 
constraints, power differentials and language norms 
[12,13].  
The process of priority setting may particularly benefit 
from diverse stakeholder input, insofar as it promotes 
improved decision-making, stakeholder satisfaction and 
positive externalities such as media coverage or policy 
change [10,18]. Deliberative approaches to stakeholder 
engagement show particular promise for priority setting. 
Such events entail careful design of the deliberation 
process, an emphasis on facilitation and attention to the 
ways that stakeholders relate to each other [19,20]. 
Facilitators foster safe environments for information 
sharing, especially when stakeholder interests may be 
perceived as incompatible or when consensus must be 
achieved [11,21]. Distinct from survey or focus group 
approaches that elicit more initial and intuitive responses 
from participants, deliberative events aim to provide 
participants with information that is intentionally neutral 
and respectful of the full range of underlying values, 
experiences and possible perspectives. Participants are 
encouraged to discuss, learn from others and examine and 
refine their own views [22]. Collective problem solving is 
emphasized, along with exploration of different 
perspectives, consensus building and active participation 
by all stakeholders in a process that seeks to minimize 
status differentials [11,20,23].  
A limited literature suggests that facilitated public 
deliberation can successfully engage stakeholders to 
prioritize CER questions [10]. Various deliberative 
strategies have improved participant knowledge and 
influenced participant opinions [22].  In-person (versus 
remote) methods may provide more valued experiences 
[22].   
We report here on the PaTH Health System Leader’s 
Demonstration Project (HSLDP), which aimed to engage 
health system and health plan leaders, along with other 
stakeholders, in prioritizing CER questions. We describe 
and evaluate the deliberative process used to promote in-
person dialogue, allow participants to listen to each other’s 
perspectives in real time, reflect on and react to these 
perspectives and interact directly to reach a better 







The PaTH Clinical Data Research Network is a member of 
the National Patient-Centered Clinical Research Network 
(PCORnet) [24]. PaTH is a partnership between 6 health 
systems (Geisinger Health System, Johns Hopkins Health 
System, Penn State Milton S. Hershey Medical Center, 
Temple University Health System, UPMC and the 
University of Utah Health Care), their affiliated academic 
institutions and, in some cases, health plans. The HSLDP 
sought to engage health system leaders, clinicians and 
patients from across PaTH to gain insight about critical 
topics in health systems research and disseminate 
information about PCORnet. Goals included informing the 
development of a grant proposal seeking funds to answer 
the highest priority CER question and fostering longer-
term collaboration with health system leaders.  
A deliberative format was selected to foster learning 
among stakeholders. Health system and health plan leaders 
were invited to provide “content expertise,” bringing direct 
expertise and insights on health system concerns. Patients, 
community engagement experts and clinicians, were 
invited as “citizen advisors” bringing values, patient 
perspectives and clinical context to the discussion. We 
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engaged a facilitator team with expertise in public 
discourse and deliberative democracy. 
Two facilitators, one clinician researcher and 2 patient 
partners planned the deliberative process. Special emphasis 
was placed on communicative practices to enact shared 
understanding across different backgrounds. Key 
challenges included ensuring that patient partners were 
empowered to participate, thereby reducing perceived 
power imbalances that can exist between them and experts 
[20] and fostering effective conversation between 
individuals with diverse backgrounds. The plan 
incorporated key features for priority setting in health 
services research, such as an explicit and transparent 
process, a focus on information management, a 
consideration of the context and values of all key 
stakeholder groups and a formal mechanism for reviewing 




“Specific research topics” of importance to health systems 
were identified from the literature and by surveying PaTH-
affiliated clinicians and health system leaders. We mapped 
these specific topics to more general strategies for 
improving health systems, expressed in language that is 
accessible to a non-technical audience (Table 1). Prior to 
the event, all patient stakeholders were invited to 
participate in a 2-hour telephone orientation to the 
deliberative goals and process. In addition, preparatory 
materials were distributed to participants, including an 
outline of the deliberation plan and topic-specific one-page 




The deliberative event included 8 stages (Figure 1). 
Techniques were employed to heighten potential for 
emergence of “social knowledge” and group opinion 
formation. For example, interim opinion polling (after 
Stage 5) and participant-driven format revision for 
comparative deliberation (Stage 5) facilitated ‘dynamic 
updating,’ which can promote social learning and group 
opinion formation in deliberative exercises [25,26]. 
A 10-topic slate was the starting point for deliberation 
(Stage 1). Participants were tasked with narrowing the list 
to 2 to 3 top-priority topics. Patients/community advocates 
and clinicians were asked to focus attention on the general 
strategies for improving health systems. Conversely, health 
system and health plan leaders were asked to focus more 
on the specific research topics, which were framed in 
technical language to enable precise discussion. To 
moderate multiple forms of expertise, facilitators explicitly 
acknowledged that patients and clinicians were invited, but 











Deliberation began within break-out groups which 
included all 3 types of participants and concentrated on 
general research strategies (Stage 2). Patients were asked 
to open the discussion in order to frankly address the risk 
of perceived status inequities that might emerge. They set 
the tone for dialogue by identifying which general strategy 
was their top priority, illustrating their choice with a 
personal narrative. Such narrative communication 
facilitates mutual understanding across diverse frames of 
reference [27]. Open discussion among participants 
followed, focusing on how to prioritize among the general 
strategies. Each group’s facilitator summarized the 
discussion in a report back to the larger group and then 
patient/community advocates and clinicians used ARS 
polling to identify their top-priority general strategy.  
During positive vetting (Stage 3), for each specific 
research topic, participants were asked to identify potential 
benefits it could provide to health systems, clinicians, 
patients  and  patient  families;  to  delineate  how  these 










Specific Research Questions 
 
Helping healthcare providers make better 
treatment recommendations  
  
A. Electronic Health Record (EHR) data should be used to monitor health system performance on 
diverse measures of unnecessary care, as outlined in the “Choosing Wisely” initiative (e.g., 
unnecessary antibiotic prescribing, unnecessary laboratory testing, unnecessary use of medical 
imaging) 
B. EHR data should be used to characterize the diagnoses and procedures associated with 23 hour 
admissions and determine whether subsequent healthcare utilization differs for similar patients 
treated with and without a 23 hour admission approach  
C. Dispensing data held within EHRs should be used to quantify how often brand-name versus 
generic drugs are used for patients treated in different healthcare settings (e.g., inpatient, 
outpatient, emergency department). Further characterization by specific patient characteristics 
will provide useful information to policy-makers aiming to promote the use of generic 
medication 
D. Health record data should be utilized to identify patient/treatment characteristics which result in 
admission vs discharge from the emergency department for common conditions (e.g., atrial 
fibrillation) and whether implementation of clinical care pathways impact this decision 
E. EHR data should be utilized to determine the care gap that exists in the management of 
osteoporosis and other diseases of aging. EHR can be used to provide automated notifications 
to both PCPs and their patients of an existing care gap that could save millions in healthcare 
costs via interventional or preventive care 
Making healthcare performance data more useful  F. Existing health system metrics should be evaluated to determine which metrics predict 
outcomes that matter to health system leaders (e.g., health outcomes, health system utilization)  
Making sure that when people are discharged 
from the hospital, they are ready and have the 
help they need to continue to improve  
G. Health record data should be used to identify patient characteristics and clinical situations that 
are associated with hospital re-admissions, enabling the development of policies that may 
reduce re-admission risk  
Understanding why some people use so much 
more healthcare resources than others  
H. Longitudinal health record data should be used to characterize high-utilizers of healthcare 
(general care or ED care), to identify which services they most often utilize and to examine 
how their health service utilization evolves over time  
I. EHR data should be used to characterize patients with multiple co-morbidities and among 
those patients, differentiate those with poor health outcomes from those with better health 
outcomes  
J. EHR data should be used to characterize common end-of-life care and determine which 
treatments are associated with both guideline-concordant care and reduced health service 
utilization  
 
benefits aligned with organizational priorities and to 
recognize when topics could be addressed with easily 
accessible data. This exercise aimed to generate an 
inventory of talking points for later PaTH advocacy of 
possible research topics to research funders. Stage 4, 
comparative deliberation, addressed reasons why some 
topics were superior to others, enabling participants to test 
the preliminary talking points. Facilitator cues steered 
participants to use constructive criticism to highlight 
limitations of the proposed research topics. 
Additional break-out sessions allowed clinicians and 
patients/community advocates, in separate groups, to 
reflect on the prior discussion and prepare to provide the 
larger group with feedback on how well their perspectives 
had been represented (Stage 5). Concurrently, health 
system and health plan leaders used ARS polls to address 
how important further deliberation was for each specific 
research topic. This activity laid the groundwork for a 
deeper comparative discussion focused on vetting a select 
few of the research topics. Re-convening, clinicians and 
patients/community advocates were polled to see if 
perspectives had shifted regarding preferences for general 
research strategies. Participants in each stakeholder group 
also reported on how well they felt that their group’s 
perspective was represented in the deliberation process. 
These polls helped the facilitators assess the need to adjust 
deliberation procedures. 
A final round of whole-group deliberation (Stage 6) 
addressed the topics identified as needing further 
discussion by the health system/health plan leaders. 
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Participants then voted on the specific research topic of 
highest priority. The event ended with a preliminary 
discussion of how to operationalize the prioritized topic 
and a summary of the planned decision-making process 
that would be used moving forward (Stage 7). That is, the 
final choice of specific research questions would be 
determined by PaTH’s Steering Committee, after reflecting 
on data gathered throughout the deliberation event. To 
ensure communicative accountability, the final decision 
and rationale would be circulate to the entire group that 
had participated in the deliberation process. We assessed 
for opinion shift on general topics between the initial and 
follow-up audience-response using Chi-square tests. 
Because of the limited sample size, responses from 
patients, community advocates and clinicians were 
combined for this analysis. An exit poll provided a formal 
process evaluation [28], assessing markers of successful 
deliberation [22] and stakeholder engagement [20].  Data 





Eleven health system leaders, 5 health plan leaders, 8 
clinicians and 5 patients or community advocates gathered 
in Pittsburgh PA, on November 9, 2015, for the 4.5-hour 
deliberation event. Health system and health plan leaders’ 
roles were diverse, such as hospital president, chief 
executive officer, chief information officer, director of 
behavioral health, vice president of operations and senior 
vice president. Baseline polls on general strategies showed 
that among the patients and community advocates, the 
preferred general strategy was helping healthcare providers 
make better treatment recommendations (80%), with a 
minority selecting the topic focusing on adequate post-
hospitalization care (20%; Figure 2). Among clinicians, 
63% initially preferred a focus on understanding why some 
patients use more healthcare resources than others; 25% 
favored a focus on ensuring that patients discharged from 
the hospital have the help they need to continue to improve 
and 13% preferred focusing on making healthcare 
performance data more useful. 
The positive vetting process identified valuable aspects 
of all proposed topics. Comparative deliberation then 
focused on differentiating the relative value of topics - in 
particular, topics related to over-use of care and hospital 
re-admissions. In the second break-out session (Stage 5), 
health system/health plan leaders identified 3 topics for 
which further deliberation was important: (a) high utilizers 
of care (86%); (b) health system metrics (69%) and 
unnecessary care (56%). Focused deliberation on this set of 
topics set the stage for final group polling. 
Eleven participants (4 patients or community advocates 
and 7 clinicians) participated in the initial and follow-up 
polls assessing general strategy preference (1 patient and 1 
clinician voted only at baseline). While 45% initially 
preferred the topic “Understanding why some people use 
so much more healthcare resources than others, 64% 
preferred the same topic at the conclusion of deliberation 
(p=0.015; Figure 3). The shift in responses occurred 
entirely among clinicians, with the 4 patients/community 
advocates maintaining consistent preferences. 
 
Figure 2 Responses to baseline poll on 
preferred general strategy. Participants 
answered the question “Which of the following 
seems most promising?” 
 
 
Figure 3 Comparison of preferred strategy 
preferences prior to and following deliberation. 
Responses reflect 4 patients/community 
advocates and 7 clinicians 
 
 
Despite a range of initial preferences for specific 
research topics, the final poll showed preferences 
converging on a single topic: “Understanding what drives 
high utilization of care” (55% of respondents). Several 
other topics received a low percentage of votes (hospital 
re-admissions 14%; health system metrics 14%; 
unnecessary care 10%; multiple comorbidities 3%; care 
gaps for diseases of aging 3%). Physical and mental health 
contributions to high use of care were both of high 
importance. 
The interim process evaluation showed high 
satisfaction levels. When asked how they felt about the 
way that the patient perspective had been represented so 
far in the deliberation, 80% of patient respondents  were 
 






Table 2 Perceptions about the deliberation event among the 26 participants who participated in the 
evaluation survey [frequency (%)] 
 
Those people whose lives are most impacted by the issues we discussed 
were well represented in this process. We heard a broad range of diverse opinions 
 Strongly agree 7 (27)  Strongly agree 10 (38) 
Agree  14 (54) Agree 10 (38) 
Neither agree nor disagree 4 (15) Neither agree nor disagree 5 (19) 
Disagree 1 (  4) Disagree 0 (  0) 
Strongly disagree 0 (  0) Strongly disagree 0 (  0) 
No answer 0 (  0) No answer 1 (  4) 
The group was diverse enough to make sure that a wide range of views 
were considered 
I had enough information to participate effectively 
 Strongly agree 9 (35)  Strongly agree 8 (31) 
Agree 15 (58) Agree 14 (54) 
Neither agree nor disagree 1 (  4) Neither agree nor disagree 2 (  8) 
Disagree 1 (  4) Disagree 1 (  4) 
Strongly disagree 0 (  0) Strongly disagree 0 (  0) 
No answer 0 (  0) No answer 1 (  4) 
I had ample opportunity in the small group discussions to express my views I learned a lot from participating in this process 
 Strongly agree 20 (77)  Strongly agree 9 (35) 
Agree 5 (19) Agree 15 (58) 
Neither agree nor disagree 0 (  0) Neither agree nor disagree 1 (  4) 
Disagree 0 (  0) Disagree 0 (  0) 
Strongly disagree 0 (  0) Strongly disagree 0 (  0) 
No answer 1 (  4) No answer 1 (  4) 
My fellow participants respected what I had to say, even when they didn't 
agree with me 
My views on the issues changed as a result of this process 
 Strongly agree 17 (65)  Strongly agree 0 (  0) 
Agree 8 (31) Agree 14 (54) 
Neither agree nor disagree 0 (  0) Neither agree nor disagree 10 (38) 
Disagree 0 (  0) Disagree 2 (  8) 
Strongly disagree 0 (  0) Strongly disagree 0 (  0) 
No answer 1 (  4) No answer 0 (  0) 
Overall, I feel that people expressed what was truly on their mind The process helped me empathize with the challenges of others 
 Strongly agree 13 (50)  Strongly agree 7 (27) 
Agree 12 (46) Agree 15 (58) 
Neither agree nor disagree 0 (  0) Neither agree nor disagree 3 (12) 
Disagree 0 (  0) Disagree 1 (  4) 
Strongly disagree 0 (  0) Strongly disagree 0 (  0) 
No answer 1 (  4) No answer 0 (  0) 
 
either satisfied (60%) or very satisfied (20%) and another 
20% neutral. When clinicians were asked to evaluate how 
their perspective had been represented, 13% reported very 
satisfied; 60% satisfied and 20% neutral.  
The process evaluation survey was completed by 26 
participants (90%). Mean (SD) age was 56 (11.0); 50% 
were female and race was predominantly white (81% 
white, 8% African American, 12% Asian). Of respondents, 
58% self-identified as a health system leader, 4% as a 
health plan leader, 23% as a clinician, 12% as a patient and 
4% as a community engagement expert. When asked about 
satisfaction with the overall process, 65% were satisfied 
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and 35% very satisfied. Respondents reported a wide range 
of familiarity with the issues that were the focus of the 
event: 54% very familiar, 42% somewhat familiar and 4% 
can’t say. None reported being somewhat unfamiliar with 
the issues. Facilitators were generally felt to be unbiased 
(77% completely unbiased; 19% mostly unbiased; 4% can't 
say). 
Most survey respondents felt that the people most 
impacted by the issues discussed were well-represented by 
the deliberation process (27% strongly agreed; 54% 
agreed) and that the group was sufficiently diverse to 
ensure a wide range of viewpoints (35% strongly agreed; 
58% agreed; Table 2). Respondents reported sufficient 
opportunity to express their views in the small group 
discussions. They felt their fellow participants respected 
what they had to say, even when having differing views. 
Participants agreed that people expressed what was truly 
on their mind and most noted having heard a broad range 
of opinions. Most, but not all, reported sufficient 
information to participate effectively. The majority agreed 
(35% strongly agreed; 58% agreed) that they learned a lot 
from participating. Over half noted that their views on the 
issues changed as a result of deliberation (54%) and that 
the process helped them empathize with the challenges of 





The HSLDP demonstrates that a deliberative forum can 
effectively engage health system/health plan leaders, along 
with other stakeholders, to prioritize CER questions of 
value to health systems. Participants reported high levels of 
satisfaction with the process. Key recommendations for 
stakeholder engagement were met, such as respect (100% 
felt their fellow participants respected what they had to 
say), legitimacy (the stakeholder group was noted to be 
sufficiently diverse), fairness (decisions and rationales 
were made public), competence (participants had sufficient 
information to participate effectively) and accountability 
[20]. The event also demonstrated high deliberative quality 
[22]. Respondents noted that they had ample opportunity 
for active participation and adequate discussion, respect for 
others’ opinions and awareness of different perspectives. 
Participants reported other markers of successful 
deliberation such as impact on knowledge (93% learned 
from the experience) and attitudes (54% noted their views 
on the issues changed) about the topics and that the process 
helped them to empathize with the challenges of others 
(85% agreed) [22].  
Our deliberative format design emphasized 
synchronous, face-to-face interaction between participants 
from different backgrounds. By bringing together 
stakeholders (health system leaders, clinicians and 
patients), the event created conditions for social knowledge 
to emerge. Social knowledge “depends on a personal 
relationship to other actors in the social world” and it 
“becomes the emergent property of a collectivity” when 
people communicate collaboratively to develop 
overlapping opinions on practical questions [29]. Social 
knowledge can be distinguished from the knowledge 
generated from survey data or public opinion polls, which 
aggregate static preferences expressed by individuals from 
within insular frames of reference. By contrast, when 
groups gather to deliberate, communication can trigger 
social learning processes that enable individuals to reassess 
and potentially revise their previously settled positions. 
When such deliberating groups draw upon the diverse 
horizons of experience and expertise shared by 
heterogeneous individuals, this collective learning process 
can yield social knowledge that is particularly robust. 
A frequent outcome of group deliberation is opinion 
change [26,30], which was demonstrated at our event. 
Such findings suggest that the iterative discussion 
promoted learning and potentially fostered new insights as 
the various stakeholders learned of each other’s 
perspectives. 
A unique aspect of this event is its link to PaTH’s and 
PCORnet’s research agenda. PCORnet has subsequently 
proceeded with research on the high-priority topic area 
identified by PaTH’s Health System Leaders’ 
Demonstration Project - validating the outcome of this 
deliberation process. The genre of “empowered 
deliberation” is receiving heightened attention in the 
communication literature, with studies exploring how 
citizen and stakeholder deliberation can sometimes be 
linked, directly or indirectly, to decision-making within 
institutions [31]. Johnson and Gastil’s scheme for ordering 
varieties of empowered deliberation highlights a gap in the 
literature regarding what they call “embedded and 
provisional” deliberation that takes place in a single, trans-
local event. Further study might usefully explore how the 
PaTH HSLDP can be viewed in this light, potentially 
illuminating the dynamic interplay between stakeholder 
deliberation and institutional decision-making. 
Limitations include the fact that deliberative models 
require substantial time and effort to plan and execute [11] 
and CER teams typically do not include deliberation 
facilitators. Furthermore, stakeholders who do not 
routinely make health system decisions may find it 
difficult to reconcile personal advocacy agendas with a 
health system leader point of view. Varying the 
composition of the different end-users of the research 
among a stakeholder group could result in substantially 
different input into the CER process [11]. Yet, prior 
research indicates that while participants from historically 
under-represented demographic groups may place more 
value on or perceive greater impact from their participation 
in a deliberative forum than other participants, the 
proportion of discussants made up of a specific 
demographic group may minimally affect deliberative 
outcomes [22]. Furthermore, polarization (the systematic 
tendency of groups and the individuals who compose them 
to strengthen their pre-deliberation opinions) does not 
appear to be common using deliberative approaches [22]. 
The relatively small sample size that was assessed for 











In summary, we found that a deliberative forum effectively 
engaged diverse health system/health plan leaders to 
prioritize CER topics. Productive conversation was 
fostered among stakeholders with various perspectives 
(e.g., health system leaders, patients, clinicians). The 
format was satisfactory to participants, who reported 
successful engagement and deliberative experiences. 
Opinions shifted during deliberation, suggesting that the 
in-person iterative discussion promoted learning. 
Deliberation may represent an important tool for 
incorporating diverse stakeholder into the CER process, 
such that participants can inform and learn from each 
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